Heiko Schipper - Bayer AG Executive
| BAYZF Stock | USD 25.96 0.05 0.19% |
Executive
Mr. Heiko Schipper was Member of the Management Board and Head of the Consumer Health Division at Bayer Aktiengesellschaft since March 1, 2018. He completed his Master in Business Economics at the Erasmus University in Rotterdam, the Netherlands. Starting in 1994, he acquired his first professional experience at Heineken. He joined Nestle as an international marketing trainee in 1996, developing his career in sales and marketing management roles in Bangladesh and Indonesia and at the company global headquarters in Switzerland. He then took up general management roles of increasing importance in the Philippines and, from 2007 to 2013, in the Greater China Region with the aim of developing Nestle position in this key market. In 2013, Mr. Schipper moved back to Switzerland to lead the global Infant Nutrition Division, a business with both consumer and medical characteristics. He was appointed to the Nestle Group Executive Board in October 2014. since 2018.
| Age | 54 |
| Tenure | 7 years |
| Phone | 49 214 30 1 |
| Web | https://www.bayer.com |
Bayer AG Management Efficiency
The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.13 %, meaning that it generated $0.13 on every $100 dollars invested by stockholders. Bayer AG's management efficiency ratios could be used to measure how well Bayer AG manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Christy Cornet | Aviat Networks | N/A | |
| Ming Hsu | United Microelectronics | N/A | |
| ShingRen Sheu | United Microelectronics | N/A | |
| Steven Liu | United Microelectronics | N/A | |
| Muliang Liao | United Microelectronics | N/A | |
| Lauren Geer | IAC Inc | N/A | |
| M Hsu | United Microelectronics | N/A | |
| M Lai | United Microelectronics | N/A | |
| Zhenlun Zhang | United Microelectronics | N/A | |
| Igor Samartsev | IPG Photonics | 62 | |
| Joshua Koplik | IAC Inc | N/A | |
| Robert Larson | Albertsons Companies | 54 | |
| CJ Hu | United Microelectronics | N/A | |
| Mark CPA | IAC Inc | N/A | |
| SS Hung | United Microelectronics | N/A | |
| Steve JD | Titan Machinery | N/A | |
| Thomas Moriarty | Albertsons Companies | 61 | |
| Edward Ferguson | IAC Inc | N/A | |
| Francia Hsu | United Microelectronics | N/A | |
| Jason Anderson | Titan Machinery | N/A | |
| Valerie Combs | IAC Inc | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 |
Bayer AG Leadership Team
Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarena Lin, Labor Officer | ||
| Oliver Maier, Head Relations | ||
| Gabriel Harnier, Patents Law | ||
| Heiko Schipper, Member of the Management Board, Head of the Consumer Health Division | ||
| Rodrigo Santos, Member Division | ||
| Michael Preuss, Gov Communications | ||
| Stefan Oelrich, Member of the Management Board, Head of the Pharmaceuticals Division | ||
| Wolfgang Nickl, CFO, Member of the Management Board | ||
| BerndPeter Bier, Head Taxes | ||
| Werner Baumann, Chief Strategy and Portfolio Officer and Member of Management Board |
Bayer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Bayer AG a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 87.41 B | |||
| Shares Outstanding | 982.42 M | |||
| Shares Owned By Institutions | 47.11 % | |||
| Price To Earning | 321.83 X | |||
| Price To Book | 1.36 X | |||
| Price To Sales | 1.06 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Bayer Pink Sheet
Bayer AG financial ratios help investors to determine whether Bayer Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.